TORONTO, ONTARIO -- (Marketwired) -- 07/04/13 -- Imperial Capital Group of Toronto is pleased to announce the sale of the Clinical Services business of AIM Health Group Inc., an Imperial Capital Acquisition Fund IV portfolio company. AIM was originally acquired in August 2011 through a take-private transaction executed by Imperial Capital together with the support of its founder and CEO, Dr. Lu Barbuto.
AIM is a diversified Canadian healthcare company recognized for its leadership in pain management, infusion services, workplace health, and corporate disability management. The Clinical Services business was comprised of community-based medical clinics as well as one of the largest networks of nurse-supervised infusion clinics in the country. Since the take-private transaction, the Imperial Capital team, together with management, executed on an aggressive growth and acquisition driven strategy. This process identified several new growth opportunities and required the Company to seek a new strategically aligned partner.
"We are very pleased with this transaction," stated Justin MacCormack, Partner and healthcare practice leader at Imperial Capital, "as it provides AIM with a strong partner for future growth and our investors realized an attractive return of over two times our original investment in less than two years."
Jeffrey Rosenthal, Managing Partner of Imperial Capital added "we are pleased that our first Canadian healthcare investment has been so successful and we look forward to Imperial's ongoing investment in North American healthcare companies."
AIM was the second healthcare investment for Imperial Capital following the acquisition of Schulman Associates Institutional Review Board, Inc. in 2008. Imperial continues to be a Canadian healthcare investor through its remaining investment in AIM's Corporate Services business which will now operate as Workplace Health and Cost Solutions Ltd.
Founded in 1989, Imperial Capital is a Toronto-based private equity firm with a strong track record of acquiring and building entrepreneurial and family-owned businesses in the Canadian and American middle markets. Imperial Capital works with high-calibre management teams and industry-experienced CEO Partners to accelerate growth and enhance the operating performance of its portfolio companies. Imperial Capital's current investments include Schulman Associates Institutional Review Board, Inc. (pharmaceutical services), Petra Pet, Inc. (owner of Beefeaters®, Petra Vet®, and Nutri-Vet®; pet treats, consumables, and nutraceuticals), and Lise Watier Cosmetiques Inc. (cosmetics, skincare, and fragrances).
For further information on Imperial Capital, please go to www.imperialcap.com.
Imperial Capital Group Ltd.
Most Popular Stories
- American Airlines, US Airways Complete Merger
- Dell Offers Undisclosed Number of Employee Buyouts
- ACA Delay Stresses Small Businesses
- Saab Gets Back into the Game; U.S. Auto Sales Soar
- General Dynamics Plans 200 New Jobs in N.M.
- Unemployed Wait as Lawmakers Debate
- Authorities Close to Deal with JPMorgan Chase over Madoff Response
- Questions Remain in Jenni Rivera's Death
- U.S. Stocks Rise on Sysco Acquisition
- Tech Giants Call for Controls on Government Snooping